Difficult-to-dose Opioids and the Risk Evaluation Mitigation Strategy

US Pharmacist 

In This Article

Abstract and Introduction


On behalf of patient safety considerations, providers must receive the support for safely switching patients to and from oral fentanyl products. This could be accomplished with the upcoming implementation of the Risk Evaluation Mitigation Strategy (REMS) for opioids.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.